A Study for Patients With Secondary Progressive Multiple Sclerosis

Clinical trial NCT00869726 · COMPLETED

Trial details

NCT number: NCT00869726
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Secondary Progressive Multiple Sclerosis

Start date: 2004-12-01
Primary completion: 2009-05-01
Enrollment: 596

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.